Cancer Incidence and Mortality for All Sites of Cancer, Monroe County, 2008-2012

Source: New York State Cancer Registry

Site of Cancer Incidence Mortality
Males Females Males Females
Average Annual Cases Rate per 100,000 Males 95% CI (+/-) Average Annual Cases Rate per 100,000 Females 95% CI (+/-) Average Annual Deaths Rate per 100,000 Males 95% CI (+/-) Average Annual Deaths Rate per 100,000 Females 95% CI (+/-)
All Invasive Malignant Tumors 2169.0 576.3 11.1 2172.4 465.2 9.0 743.8 203.0 6.6 776.2 154.9 5.0
Oral cavity and pharynx
All Oral cavity and pharynx 60.2 15.3 1.8 42.2 8.7 1.2 12.2 3.1 0.8 6.4 1.2 0.4
Lip 3.0 0.8 0.4 2.2 0.4 0.3 0.2 0.0 0.1 0.0 0.0 0.0
Tongue 19.4 4.9 1.0 12.2 2.5 0.6 2.4 0.6 0.3 1.0 0.2 0.2
Salivary gland 6.4 1.7 0.6 5.6 1.2 0.4 0.8 0.2 0.2 1.4 0.3 0.2
Floor of mouth 3.6 0.9 0.4 2.2 0.4 0.3 0.2 0.0 0.1 0.2 0.0 0.1
Gum & other mouth 7.4 1.9 0.6 10.2 2.1 0.6 1.0 0.3 0.2 1.0 0.2 0.2
Nasopharynx 1.0 0.3 0.2 0.8 0.2 0.2 1.6 0.5 0.3 0.2 0.1 0.1
Tonsil 11.6 2.8 0.7 5.0 1.1 0.4 1.2 0.3 0.2 0.4 0.1 0.1
Oropharynx 3.2 0.7 0.4 1.6 0.3 0.2 2.4 0.6 0.4 1.0 0.2 0.2
Hypopharynx 3.6 0.9 0.4 2.0 0.4 0.3 0.8 0.2 0.2 0.2 0.0 0.1
Other buccal cavity and pharynx 1.0 0.2 0.2 0.4 0.1 0.1 1.6 0.4 0.3 1.0 0.2 0.1
Digestive system
All Digestive system 378.8 99.8 4.6 329.2 67.1 3.3 203.4 54.7 3.4 174.8 33.9 2.3
Esophagus 34.2 8.9 1.4 9.4 1.8 0.5 34.6 9.2 1.4 8.4 1.7 0.5
Stomach 39.0 10.6 1.5 21.2 4.5 0.9 17.2 4.8 1.0 11.6 2.4 0.6
Small intestine 12.8 3.4 0.9 9.4 2.1 0.6 3.0 0.9 0.4 2.8 0.5 0.3
Colorectal 165.2 43.7 3.0 184.8 37.5 2.5 56.2 15.3 1.8 69.8 13.3 1.5
Colon excluding rectum 104.0 27.8 2.4 136.2 27.1 2.1 45.2 12.5 1.7 58.2 11.0 1.3
Cecum 24.2 6.5 1.2 34.0 6.5 1.0            
Appendix 6.0 1.6 0.6 3.8 0.8 0.4            
Ascending colon 17.0 4.6 1.0 31.0 5.9 1.0            
Hepatic flexure 5.0 1.3 0.5 6.2 1.3 0.5            
Transverse colon 9.8 2.6 0.8 12.8 2.5 0.6            
Splenic flexure 2.8 0.7 0.4 3.4 0.6 0.3            
Descending colon 5.0 1.3 0.5 7.4 1.6 0.5            
Sigmoid colon 28.6 7.5 1.3 29.6 6.3 1.0            
Large intestine, NOS 5.6 1.6 0.6 8.0 1.6 0.5            
Rectum & rectosigmoid 61.2 15.9 1.8 48.6 10.4 1.3 11.0 2.9 0.8 11.6 2.4 0.6
Rectosigmoid junction 14.4 3.8 0.9 12.8 2.6 0.7            
Rectum 46.8 12.1 1.6 35.8 7.8 1.2            
Anus, anal canal & anorectum 7.0 1.8 0.6 9.0 1.8 0.5 1.8 0.5 0.3 1.2 0.2 0.2
Liver and intrahepatic bile duct 43.0 11.0 1.5 15.2 3.2 0.7 34.0 8.9 1.4 18.6 3.7 0.8
Liver 39.0 9.9 1.4 11.8 2.5 0.7 24.6 6.3 1.1 9.2 1.9 0.6
Intrahepatic bile duct 4.0 1.1 0.5 3.4 0.7 0.4 9.4 2.6 0.8 9.4 1.8 0.5
Gallbladder 3.2 0.9 0.5 3.4 0.7 0.3 1.2 0.3 0.3 2.4 0.5 0.3
Other biliary 9.8 2.5 0.7 8.2 1.6 0.5 2.4 0.6 0.4 1.8 0.3 0.2
Pancreas 58.8 15.5 1.8 58.2 11.6 1.4 51.2 13.7 1.7 54.4 10.4 1.3
Retroperitoneum 3.0 0.8 0.4 2.4 0.6 0.3 0.2 0.1 0.1 0.2 0.0 0.1
Peritoneum, omentum & mesentery 0.4 0.1 0.1 5.6 1.2 0.4 0.6 0.1 0.2 1.0 0.2 0.2
Other digestive organs 2.4 0.7 0.4 2.4 0.5 0.3 1.0 0.3 0.3 2.6 0.5 0.3
Respiratory system
All Respiratory system 312.0 83.6 4.2 302.4 62.6 3.2 221.8 60.1 3.6 209.6 42.9 2.7
Nasal cavity, middle ear & sinuses 3.4 0.9 0.4 3.6 0.8 0.4 0.8 0.2 0.2 1.0 0.2 0.2
Larynx 24.2 6.4 1.2 5.2 1.1 0.4 7.8 2.0 0.6 4.0 0.8 0.4
Lung and bronchus 283.8 76.1 4.0 293.2 60.6 3.2 212.8 57.7 3.5 204.4 41.9 2.6
Trachea, mediastinum, other respiratory 0.6 0.2 0.2 0.4 0.1 0.1 0.4 0.1 0.2 0.2 0.0 0.1
Soft tissue, bone, and skin
Bones & joints 5.0 1.3 0.5 3.4 0.8 0.4 2.4 0.6 0.4 1.2 0.3 0.2
Soft tissue (including heart) 14.8 4.0 0.9 14.2 3.4 0.8 6.0 1.6 0.6 7.4 1.5 0.5
Skin~ 111.2 30.7 2.6 92.2 21.3 2.0 19.8 5.4 1.1 11.8 2.3 0.6
Melanoma of the skin 102.0 28.0 2.5 85.6 20.0 1.9 14.4 3.9 0.9 8.8 1.8 0.5
Breast
Breast 4.4 1.2 0.5 646.2 141.4 5.0 1.0 0.3 0.3 112.4 22.7 1.9
Female genital system
All Female genital system       247.8 52.8 3.0       83.6 16.9 1.7
Cervix uteri       24.4 5.8 1.1       7.0 1.6 0.5
Corpus uterus and NOS       145.4 30.5 2.3       27.8 5.5 0.9
Ovary       55.4 11.9 1.5       43.4 8.9 1.2
Vagina       2.2 0.4 0.3       0.4 0.1 0.1
Vulva       14.8 3.0 0.7       2.8 0.5 0.3
Other female genital organs       5.6 1.1 0.4       2.2 0.4 0.2
Male genital system
All Male genital system 644.4 166.4 5.9       66.0 18.8 2.0      
Prostate 617.0 158.4 5.7       64.2 18.3 2.0      
Testis 23.4 6.9 1.3       0.6 0.1 0.2      
Penis 3.6 1.0 0.5       1.2 0.4 0.3      
Other male genital organs 0.4 0.1 0.2       0.0 0.0 0.0      
Urinary system
All Urinary system 263.0 71.6 3.9 107.2 22.2 1.9 55.6 15.3 1.8 21.4 3.9 0.8
Urinary bladder (including in situ) 159.0 44.3 3.1 49.6 10.0 1.3 32.4 9.1 1.4 10.2 1.7 0.5
Kidney and renal pelvis 97.6 25.5 2.3 55.2 11.7 1.4 22.0 5.8 1.1 10.6 2.0 0.6
Ureter 1.8 0.5 0.3 0.8 0.2 0.2 0.6 0.2 0.2 0.0 0.0 0.0
Other urinary organs 4.6 1.3 0.5 1.6 0.3 0.2 0.6 0.2 0.2 0.6 0.1 0.1
Eye & orbit
Eye & orbit 2.2 0.6 0.3 2.0 0.4 0.3 0.0 0.0 0.0 0.6 0.1 0.1
Brain and central nervous system
All Brain / other nervous system (all behaviors) 57.4 15.4 1.8 93.4 20.9 2.0 23.2 6.4 1.2 19.2 4.1 0.8
Malignant brain / other nervous system 25.0 6.9 1.2 24.0 5.8 1.1 19.6 5.4 1.1 15.0 3.2 0.8
Malignant brain 23.4 6.4 1.2 21.6 5.1 1.0            
Malignant other nervous system 1.6 0.5 0.3 2.4 0.6 0.4            
Benign brain / other nervous system* 32.4 8.6 1.3 69.4 15.1 1.6 3.6 1.0 0.5 4.2 0.8 0.4
Benign brain 3.0 0.8 0.4 4.6 1.1 0.5            
Benign other nervous system 29.4 7.7 1.3 64.8 14.1 1.6            
Endocrine system
All Endocrine system 32.0 8.4 1.3 82.4 20.7 2.1 2.4 0.7 0.4 4.6 0.9 0.4
Thyroid 29.4 7.7 1.3 79.2 20.0 2.0 1.6 0.4 0.3 2.8 0.5 0.3
Other endocrine (including thymus) 2.6 0.7 0.4 3.2 0.7 0.4 0.8 0.2 0.2 1.8 0.4 0.3
Lymphomas
All Lymphomas 115.0 31.4 2.6 100.8 21.8 2.0 29.4 8.2 1.3 27.4 5.3 0.9
Hodgkin lymphoma 13.4 3.8 0.9 13.6 3.4 0.8 1.0 0.3 0.3 1.6 0.4 0.3
Non-Hodgkin lymphomas 101.6 27.6 2.4 87.2 18.4 1.8 28.4 7.9 1.3 25.8 5.0 0.9
Myeloma
All Myeloma 33.4 8.7 1.3 23.4 4.8 0.9 17.8 4.9 1.0 13.6 2.7 0.7
Leukemias
All Leukemias 71.0 19.4 2.1 60.8 13.2 1.5 36.6 10.2 1.5 30.4 6.2 1.0
Lymphocytic leukemias 38.4 10.3 1.5 29.6 6.4 1.1 11.0 3.0 0.8 7.8 1.5 0.5
Acute lymphocytic leukemia 3.6 1.0 0.5 3.8 1.0 0.5 1.6 0.5 0.3 1.6 0.4 0.3
Chronic lymphocytic leukemia 30.8 8.2 1.3 23.6 4.9 0.9 9.0 2.4 0.7 5.0 0.9 0.3
Other lymphocytic leukemias 4.0 1.0 0.5 2.2 0.5 0.3 0.4 0.1 0.1 1.2 0.2 0.2
Myeloid and monocytic leukemias 30.6 8.5 1.4 28.6 6.2 1.1 18.2 5.1 1.1 18.0 3.7 0.8
Acute myeloid leukemia 19.8 5.6 1.1 18.6 4.0 0.8 16.8 4.7 1.0 15.0 3.1 0.7
Acute monocytic leukemia 1.4 0.4 0.3 1.2 0.3 0.2 0.0 0.0 0.0 0.2 0.0 0.1
Chronic myeloid leukemia 8.8 2.4 0.7 8.0 1.7 0.6 1.0 0.3 0.2 1.4 0.3 0.2
Other myeloid/monocytic leukemias 0.6 0.2 0.2 0.8 0.2 0.2 0.4 0.1 0.1 1.4 0.3 0.2
Other leukemias 2.0 0.6 0.4 2.6 0.5 0.3 7.4 2.1 0.7 4.6 0.9 0.4
Other acute leukemias 1.2 0.3 0.3 1.4 0.3 0.2 4.2 1.2 0.5 1.6 0.3 0.2
Aleukemic, subacute, leukemia NOS 0.8 0.2 0.2 1.2 0.3 0.2 3.2 0.9 0.4 3.0 0.6 0.3
Mesothelioma
Mesothelioma 7.2 2.1 0.7 1.4 0.3 0.3            
Kaposi sarcoma
Kaposi sarcoma 1.6 0.4 0.3 0.0 0.0 0.0            
Myelodysplastic syndromes
Myelodysplastic syndromes 34.2 9.8 1.5 26.6 4.9 0.9            
Chronic myeloproliferative disorders^
Chronic myeloproliferative disorders^ 14.2 4.1 1.0 20.8 4.4 0.9            
Ill defined and unspecified sites
Ill defined and unspecified sites 39.4 10.6 1.5 45.4 8.5 1.2 49.8 13.8 1.7 56.0 10.8 1.3

Key

Symbol Meaning
~ Incidence of skin cancer excludes basal and squamous cell cancers.
* Brain and other nervous system tumors with benign or uncertain behaviors are not included in the total for all invasive malignant tumors.
^ Tumors with a histology of 9963 or 9964 are included under Aleukemic, Subacute, Leukemia NOS, instead of Chronic Myeloproliferative Disorder.

Notes

  • Incidence data are provisional, November 2014.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.